Will Neuland Laboratories recover after a 7% stock drop and plummeting profits?

Neuland Laboratories' shares plunged, extending losses due to investor concerns over a 59% drop in Q4 profit, despite strong guidance. Increased operating costs and reduced sales volumes triggered the decline. While the company anticipates better growth in FY26, peers have reported stronger results and promising outlooks, further impacting investor sentiment.